STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
204
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $0 priced
What the filings say about MORN
Insiders, 180 days
-$38.1M net sold
3 sellers · 9% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-05-06
Planned sales (Form 144), 90 days
$20.1M
2 notices
Morningstar insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Morningstar, Inc. insiders sold a net $38.1M of stock across 2,298 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2243 earlier Form 4 trades (code P or S) here by this insider (2243 sales), the last on Aug 21, 2026.
The trade is 0.0% of the 7,943,631 shares held after it.
1 other insider sold within 30 days.
204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Mansueto Joseph D sold about $47.5K of MORN under a 10b5-1 plan on Aug 24, 2026; 1 other insider sold within 30 days and 204 funds added in the latest 13F quarter.
2243 earlier Form 4 trades (code P or S) here by this insider (2243 sales), the last on Aug 21, 2026.
The trade is 0.0% of the 7,942,450 shares held after it.
1 other insider sold within 30 days.
204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Mansueto Joseph D sold about $256.6K of MORN under a 10b5-1 plan on Aug 24, 2026; 1 other insider sold within 30 days and 204 funds added in the latest 13F quarter.
2243 earlier Form 4 trades (code P or S) here by this insider (2243 sales), the last on Aug 21, 2026.
The trade is 0.0% of the 7,940,710 shares held after it.
1 other insider sold within 30 days.
204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Mansueto Joseph D sold about $380.1K of MORN under a 10b5-1 plan on Aug 24, 2026; 1 other insider sold within 30 days and 204 funds added in the latest 13F quarter.
2243 earlier Form 4 trades (code P or S) here by this insider (2243 sales), the last on Aug 21, 2026.
The trade is 0.0% of the 7,939,732 shares held after it.
1 other insider sold within 30 days.
204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Mansueto Joseph D sold about $214.6K of MORN under a 10b5-1 plan on Aug 24, 2026; 1 other insider sold within 30 days and 204 funds added in the latest 13F quarter.
2243 earlier Form 4 trades (code P or S) here by this insider (2243 sales), the last on Aug 21, 2026.
The trade is 0.0% of the 7,938,418 shares held after it.
1 other insider sold within 30 days.
204 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Mansueto Joseph D sold about $289.6K of MORN under a 10b5-1 plan on Aug 24, 2026; 1 other insider sold within 30 days and 204 funds added in the latest 13F quarter.
2,298 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MORN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Lyons William M
Filed 2026-08-03
$199.0K
Mansueto Joseph D
Filed 2026-08-03
$19.9M
MORN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Harbor Active Small Cap ETF
$619.9K position · as of 2026-07-31
4.4%
Leadershares Alphafactor Tactical Focused ETF
$2.6M position · as of 2026-07-31
4.0%
Baron Generational Growth Fund
$83.5M position · as of 2026-06-30
4.0%
Baron Focused Growth Fund
$113.6M position · as of 2026-06-30
2.0%
Baron First Principles ETF
$9.7M position · as of 2026-06-30
2.0%
Baron Partners Fund
$295.3M position · as of 2026-06-30
1.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Kunal Kapoor
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.1M
-$9.3M
$1.3M
-3%
+58%
2024
$8.6M
$14.5M
$3.7M
+49%
+62%
2023
$7.3M
$14.0M
$1.2M
+26%
+32%
2022
$6.3M
-$3.3M
$1.6M
-6%
-1%
2021
$5.6M
$17.0M
$1.2M
+48%
+23%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $38.1M sold by insiders over 180 days, 204 funds added last quarter, $20.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.6B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MORN
FY Dec 2025
$2.4B
FY Dec 2024
$2.3B
FY Dec 2023
$2.0B
FY Dec 2022
$1.9B
FY Dec 2021
$1.7B
Jun 2026
$663.2M
Mar 2026
$644.8M
Dec 2025
$641.1M
Sep 2025
$617.4M
Jun 2025
$605.1M
Mar 2025
$581.9M
Dec 2024
$591.0M
Sep 2024
$569.4M
At each fiscal year end
Single quarter
Net margin, TTM
+16.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MORN
FY Dec 2025
+15.3%
FY Dec 2024
+16.3%
FY Dec 2023
+6.9%
FY Dec 2022
+3.8%
FY Dec 2021
+11.4%
Jun 2026
+16.3%
Mar 2026
+16.6%
Dec 2025
+18.0%
Sep 2025
+14.8%
Jun 2025
+14.7%
Mar 2025
+13.5%
Dec 2024
+19.8%
Sep 2024
+21.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$497.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MORN
FY Dec 2025
$442.6M
FY Dec 2024
$448.9M
FY Dec 2023
$197.3M
FY Dec 2022
$168.3M
FY Dec 2021
$348.1M
Jun 2026
$122.5M
Mar 2026
$53.6M
Dec 2025
$161.3M
Sep 2025
$160.1M
Jun 2025
$62.4M
Mar 2025
$58.8M
Dec 2024
$112.8M
Sep 2024
$155.8M
At each fiscal year end
Single quarter
Debt to equity
1.69x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity MORN
FY Dec 2025
0.88x
FY Dec 2024
0.43x
FY Dec 2023
0.76x
FY Dec 2022
0.95x
FY Dec 2021
0.25x
Jun 2026
1.69x
Mar 2026
1.70x
Dec 2025
0.88x
Sep 2025
0.56x
Jun 2025
0.52x
Mar 2025
0.50x
Dec 2024
0.43x
Sep 2024
0.55x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.37x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt MORN
FY Dec 2025
0.55x
FY Dec 2024
0.85x
FY Dec 2023
0.31x
FY Dec 2022
0.26x
FY Dec 2021
1.25x
Jun 2026
0.37x
Mar 2026
0.34x
Dec 2025
0.55x
Sep 2025
0.64x
Jun 2025
0.64x
Mar 2025
0.73x
Dec 2024
0.85x
Sep 2024
0.67x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+32.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MORN
FY Dec 2025
+26.3%
FY Dec 2024
+25.1%
FY Dec 2023
+11.1%
FY Dec 2022
+5.4%
FY Dec 2021
+14.4%
Jun 2026
+32.0%
Mar 2026
+30.7%
Dec 2025
+26.3%
Sep 2025
+24.4%
Jun 2025
+26.5%
Mar 2025
+25.7%
Dec 2024
+25.1%
Sep 2024
+23.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MORN
FY Dec 2025
+10.5%
FY Dec 2024
+10.6%
FY Dec 2023
+4.1%
FY Dec 2022
+2.2%
FY Dec 2021
+7.0%
Jun 2026
+11.1%
Mar 2026
+10.6%
Dec 2025
+10.5%
Sep 2025
+10.6%
Jun 2025
+11.5%
Mar 2025
+11.0%
Dec 2024
+10.6%
Sep 2024
+9.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+17.6%
operating income after a 25.1% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MORN
FY Dec 2025
+19.8%
FY Dec 2024
+21.6%
FY Dec 2023
+9.8%
FY Dec 2022
+4.7%
FY Dec 2021
+15.4%
Jun 2026
+17.6%
Mar 2026
+16.8%
Dec 2025
+19.8%
Sep 2025
+20.6%
Jun 2025
+20.9%
Mar 2025
+21.0%
Dec 2024
+21.6%
Sep 2024
+17.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+21.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MORN
FY Dec 2025
+20.6%
FY Dec 2024
+19.0%
FY Dec 2023
+9.0%
FY Dec 2022
+7.2%
FY Dec 2021
+12.4%
Jun 2026
+21.3%
Mar 2026
+20.2%
Dec 2025
+20.6%
Sep 2025
+20.3%
Jun 2025
+19.8%
Mar 2025
+19.4%
Dec 2024
+19.0%
Sep 2024
+15.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
21.38x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MORN
FY Dec 2025
24.50x
FY Dec 2024
39.30x
FY Dec 2023
87.27x
FY Dec 2022
132.88x
FY Dec 2021
76.85x
Jun 2026
14.83x
Mar 2026
17.29x
Dec 2025
24.50x
Sep 2025
26.39x
Jun 2025
33.43x
Mar 2025
33.69x
Dec 2024
39.30x
Sep 2024
42.16x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$9.7B
market value at close 2026-10-23 on 2026-07-24 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2025-12-31
Enterprise value MORN
FY Dec 2025
$9.5B
FY Dec 2024
$14.6B
FY Dec 2023
$12.9B
FY Dec 2022
$10.0B
FY Dec 2021
$14.6B
Jun 2026
$7.2B
Mar 2026
$7.9B
Dec 2025
$9.5B
Sep 2025
$10.1B
Jun 2025
$13.6B
Mar 2025
$13.1B
Dec 2024
$14.6B
Sep 2024
$14.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield MORN
FY Dec 2025
+5.0%
FY Dec 2024
+3.1%
FY Dec 2023
+1.6%
FY Dec 2022
+1.8%
FY Dec 2021
+2.4%
Jun 2026
+8.4%
Mar 2026
+6.5%
Dec 2025
+5.0%
Sep 2025
+4.0%
Jun 2025
+2.9%
Mar 2025
+3.5%
Dec 2024
+3.1%
Sep 2024
+3.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.78x
P/E over trailing EPS growth of 12%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MORN
FY Dec 2025
7.00x
FY Dec 2024
0.24x
FY Dec 2023
0.86x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
1.23x
Mar 2026
1.75x
Dec 2025
7.00x
Sep 2025
1.64x
Jun 2025
0.52x
Mar 2025
0.42x
Dec 2024
0.24x
Sep 2024
0.12x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MORN ranks highest on profitability (82nd percentile) and growth (52nd), and lowest on insider conviction (3rd), among Financial Services peers.
Profitability
82
Inputs
Return on equity+32.0% · 88 pct, sector of 205
Return on assets+11.1% · 82 pct, sector of 266
Return on invested capital+17.6% · 66 pct, sector of 30
Return on capital employed+21.3% · 94 pct, sector of 88
Financial health
47
Inputs
Debt to equity1.69x · 22 pct, sector of 181
Cash flow to debt0.37x · 72 pct, sector of 141
Growth
52
Inputs
Revenue growth, YoY+7.5% · 43 pct, sector of 245
Backlog growth, YoY+10.0% · 60 pct, universe of 854
Insider conviction
3
Inputs
Net Form 4 buying (codes P and S), 180d-$34.4M · 6 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
43
Inputs
Funds adding, latest quarter204 · 76 pct, sector of 278
Congress net buyers, 365d-1 · 10 pct, sector of 31
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
20
Inputs
Short interest, % of float+7.3% · 27 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+60.5% · 12 pct, sector of 175
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MORN filings, in plain words
Are Morningstar insiders buying or selling MORN?
In the 180 days to 2026-10-27, Morningstar insiders were net sellers, a net $38.1M across purchases and sales reported on Form 4, by 3 sellers.
Have members of Congress traded MORN?
Yes. In the year to 2026-10-27, 0 House members disclosed buying MORN and 1 House member disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-05-06.
Are there planned insider sales of MORN?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $20.1M of stock; the latest, by Lyons William M, was filed 2026-08-03.
Read the full summary
In the 180 days to 2026-10-27, Morningstar insiders were net sellers of MORN, a net $38.1M across purchases and sales reported on Form 4 by 3 sellers. Most of that figure, $37.7M, came from a holder of 10% or more rather than an officer or director. 9% of the 138 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 0 members of Congress disclosed buying MORN and 1 member disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-05-06. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $20.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.